Sex and gender in research
The evidence is undeniable: incorporating sex and gender considerations in research and applying this knowledge to health care can significantly benefit billions of people.
In 2022, clinical trials indicated that a drug called lecanemab could slow cognitive decline in people with Alzheimer’s disease. Following the publication of these results, the global Alzheimer’s community hailed lecanemab as a groundbreaking discovery. However, closer scrutiny by independent investigators revealed that the drug might significantly bene…
Keep reading with a 7-day free trial
Subscribe to The Researcher Daily to keep reading this post and get 7 days of free access to the full post archives.